Joseph E Blaney - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Joseph E Blaney

Showing results (1-10 of 45) with videos related to

Pageof 5

Sort By:

Clinical and Vaccine Immunology : CVI|June 20, 2014

Matched longitudinal analysis of biomarkers associated with survivalLori E Dodd, Reed F Johnson, Joseph E Blaney, et al.

Nature Reviews. Microbiology|June 15, 2007

Prospects for a dengue virus vaccineStephen S Whitehead, Joseph E Blaney, Anna P Durbin, et al.

Journal of Virology|April 14, 2005

Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeysJoseph E Blaney, Jennifer M Matro, Brian R Murphy, et al.

Viral Immunology|March 24, 2006

Development of a live attenuated dengue virus vaccine using reverse geneticsJoseph E Blaney, Anna P Durbin, Brian R Murphy, et al.

Current Topics in Microbiology and Immunology|October 6, 2009

Targeted mutagenesis as a rational approach to dengue virus vaccine developmentJoseph E Blaney, Anna P Durbin, Brian R Murphy, et al.

Virology Journal|January 10, 2012

Antiviral activity of the EB peptide against zoonotic poxvirusesSharon E Altmann, Curtis R Brandt, Peter B Jahrling, et al.

Journal of Virology|December 26, 2001

Paired charge-to-alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypesKathryn A Hanley, Jay J Lee, Joseph E Blaney, et al.

BMC Infectious Diseases|October 6, 2004

Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2Joseph E Blaney, Christopher T Hanson, Kathryn A Hanley, et al.

Vaccine|August 14, 2012

Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoproteinAmy B Papaneri, Christoph Wirblich, Kurt Cooper, et al.

Journal of Virology|December 28, 2002

A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeysStephen S Whitehead, Barry Falgout, Kathryn A Hanley, et al.

Pageof 5

Search research articles

Showing results (1-10 of 45) with videos related to

Sort By:

Pageof 5

Clinical and Vaccine Immunology : CVI|June 20, 2014

Matched longitudinal analysis of biomarkers associated with survivalLori E Dodd, Reed F Johnson, Joseph E Blaney, et al.

Nature Reviews. Microbiology|June 15, 2007

Prospects for a dengue virus vaccineStephen S Whitehead, Joseph E Blaney, Anna P Durbin, et al.

Journal of Virology|April 14, 2005

Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeysJoseph E Blaney, Jennifer M Matro, Brian R Murphy, et al.

Viral Immunology|March 24, 2006

Development of a live attenuated dengue virus vaccine using reverse geneticsJoseph E Blaney, Anna P Durbin, Brian R Murphy, et al.

Current Topics in Microbiology and Immunology|October 6, 2009

Targeted mutagenesis as a rational approach to dengue virus vaccine developmentJoseph E Blaney, Anna P Durbin, Brian R Murphy, et al.

Virology Journal|January 10, 2012

Antiviral activity of the EB peptide against zoonotic poxvirusesSharon E Altmann, Curtis R Brandt, Peter B Jahrling, et al.

Journal of Virology|December 26, 2001

Paired charge-to-alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypesKathryn A Hanley, Jay J Lee, Joseph E Blaney, et al.

BMC Infectious Diseases|October 6, 2004

Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2Joseph E Blaney, Christopher T Hanson, Kathryn A Hanley, et al.

Vaccine|August 14, 2012

Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoproteinAmy B Papaneri, Christoph Wirblich, Kurt Cooper, et al.

Journal of Virology|December 28, 2002

A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeysStephen S Whitehead, Barry Falgout, Kathryn A Hanley, et al.

Pageof 5